Back
Freeport-McMoRan Vs. Akero Therapeutics Industry Stock Comparison
Buy
67
FCX
Freeport-McMoRan
Last Price:
$43.28
Seasonality Move:
3.46%
Sell
40
AKRO
Akero Therapeutics
Last Price:
$49.21
Seasonality Move:
31.84%
Buy
67
Freeport-McMoRan (FCX)
is a Buy
Is Freeport-McMoRan a Buy, Sell or Hold?
-
The current Freeport-McMoRan [FCX] share price is $43.28. The Score for FCX is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
-
FCX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
40
Akero Therapeutics (AKRO)
is a Sell
Is Akero Therapeutics a Buy, Sell or Hold?
-
The current Akero Therapeutics [AKRO] share price is $49.23. The Score for AKRO is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
AKRO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
FCX Stock Price Chart
What is Freeport-McMoRan's stock price today?
-
The Freeport-McMoRan share price today is $43.28Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FCX is experiencing buying pressure, which is a positive indicator for future bullish movement.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $49.23Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKRO is experiencing buying pressure, which is a positive indicator for future bullish movement.
FCX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 8.14 | Buy |
Relative Strength Index (14 RSI): | 56.03 | Buy |
Chaikin Money Flow: | 8842471 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (40.39 - 44.03) | Buy |
Bollinger Bands (100): | (35.98 - 44) | Buy |
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.65 | Sell |
Relative Strength Index (14 RSI): | 48.6 | Sell |
Chaikin Money Flow: | 541980 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (47.97 - 50.87) | Sell |
Bollinger Bands (100): | (41.22 - 53.36) | Buy |
FCX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 42.11 | Buy |
20-day SMA: | 41.5 | Buy |
50-day SMA: | 42.95 | Buy |
200-day SMA: | 40.1 | Buy |
8-day EMA: | 41.68 | Buy |
20-day EMA: | 35.48 | Buy |
50-day EMA: | 22.1 | Buy |
200-day EMA: | 7.17 | Buy |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 48.68 | Buy |
20-day SMA: | 48.97 | Buy |
50-day SMA: | 51.4 | Sell |
200-day SMA: | 42.35 | Buy |
8-day EMA: | 48.71 | Buy |
20-day EMA: | 49.29 | Sell |
50-day EMA: | 49.64 | Sell |
200-day EMA: | 43.29 | Buy |
Freeport-McMoRan Earnings Growth & FCX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.20 per share, an increase this year of $0.38 per share, and an increase next year of $0.85 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.13 per share, an increase this year of $0.23 per share, and a decrease next year of $0.61 per share.
Freeport-McMoRan Technical Analysis
Aug 11 | Aug 12 | Aug 13 | Aug 14 | Aug 15 | Aug 18 | Aug 19 | Aug 20 | Aug 21 | Aug 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | ||||||||||
11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Akero Therapeutics Technical Analysis
Aug 11 | Aug 12 | Aug 13 | Aug 14 | Aug 15 | Aug 18 | Aug 19 | Aug 20 | Aug 21 | Aug 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | ||||||||||
11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |